At a glance
- Nonapeptide-1 (sold as Melanostatine-5) is a brightening peptide aimed at dark spots and uneven tone.
- It works upstream of pigment, acting as an antagonist at the receptor that the hormone alpha-MSH uses to switch on melanin production.
- In laboratory studies it serves as a reference MSH-blocking agent and has been shown to interfere with melanin transfer.
- Standalone clinical trials on human pigmentation are lacking, so it is best seen as a gentle adjunct rather than a primary spot treatment.
- Evidence strength: Limited, based on cell studies and delivery research rather than clinical trials.
What is nonapeptide-1?
Nonapeptide-1, trade name Melanostatine-5, is a nine-amino-acid peptide developed to reduce excess pigment. Its design is based on blocking alpha-melanocyte-stimulating hormone (alpha-MSH), the signal that prompts pigment cells to make melanin. It appears in brightening serums and creams positioned as a gentler alternative to acids and hydroquinone.
What skin type is nonapeptide-1 best for?
It is aimed at people with hyperpigmentation, dark spots, or uneven tone who want a mild option, and because it is a peptide rather than an acid it suits most skin types, including sensitive skin. People with stubborn melasma or deep pigmentation usually need stronger, better-proven treatments.
What does nonapeptide-1 do?
It targets an early step in pigment formation. Alpha-MSH binds the melanocortin-1 receptor on pigment cells to trigger melanin synthesis, and nonapeptide-1 is designed to act as an antagonist at that pathway. In a 2022 melanogenesis study, nonapeptide-1 acetate was used as a known alpha-MSH antagonist for comparison, and a 2024 study that attached nonapeptide-1 to a delivery particle described its melanin-transfer-interfering properties and reduced melanin in treated skin. Both lines of work support the mechanism without being standalone clinical trials.
How do you know if nonapeptide-1 can help your skin?
It is reasonable to try if you want a gentle brightening ingredient to support other measures, and realistic expectations are modest fading of mild discoloration over two to three months. For established melasma or dark spots that matter to you, dermatologist-guided options have much stronger evidence.
How do you use nonapeptide-1?
Apply once or twice daily to clean skin in a serum or moisturizer. The single most important partner for any brightening routine is broad-spectrum sunscreen every morning, because sun exposure drives the pigment you are trying to reduce. Give it consistent use over weeks.
What should you use with nonapeptide-1?
It combines well with other brightening actives such as niacinamide and vitamin C, and with hydrating ingredients like hyaluronic acid. Daily sunscreen is essential alongside it. Because its own evidence is limited, it works best as one part of a tone-evening routine rather than the sole treatment.
Evidence strength
Limited: The mechanism, blocking alpha-MSH signaling to pigment cells, is biologically sound and is supported by cell-based melanogenesis research and by delivery studies showing reduced melanin. What is missing is independent clinical trials measuring the peptide's effect on hyperpigmentation in people, so its real-world brightening power is not well quantified. It is a reasonable, low-risk adjunct rather than a proven primary treatment.
References
- Chen J, Li H, Liang B, Zhu H. Effects of tea polyphenols on UVA-induced melanogenesis via inhibition of α-MSH-MC1R signalling pathway. Advances in Dermatology and Allergology. 2022;39(2):327-335. doi:10.5114/ada.2022.115890
- Huang ZJ, Zhou XH, Wen WQ, et al. Enhanced skin benefits of EGCG loaded in nonapeptide-1-conjugated mesoporous silica nanoparticles to reverse skin photoaging. International Journal of Pharmaceutics. 2024;665:124690. doi:10.1016/j.ijpharm.2024.124690














